Cell Surface Targets for Individual Cancer Patients Analyzed with Common Fund Datasets
FEATURED

Cell Surface Targets for Individual Cancer Patients Analyzed with Common Fund Datasets

Given RNA-seq samples from a patient tumor, we screen for targets which are highly expressed in the tumor but lowly expressed across all healthy human tissues in GTEx. Detailed information about the selected target are queried from several DCCs.
Cell Surface Targets for Individual Cancer Patients Analyzed with Common Fund Datasets
Mild Cognitive Impairment Use Case
FEATURED

Mild Cognitive Impairment Use Case

Find all IDG and GTEx assertions that may be related to mild cognitive impairment and any tissue type.
Mild Cognitive Impairment Use Case
Cell Surface Targets for Individual Cancer Patients Analyzed with Common Fund Datasets
FEATURED

Cell Surface Targets for Individual Cancer Patients Analyzed with Common Fund Datasets

Given RNA-seq samples from a patient tumor, we screen for targets which are highly expressed in the tumor but lowly expressed across all healthy human tissues in GTEx. Detailed information about the selected target are queried from several DCCs.
Cell Surface Targets for Individual Cancer Patients Analyzed with Common Fund Datasets
Mild Cognitive Impairment Use Case
FEATURED

Mild Cognitive Impairment Use Case

Find all IDG and GTEx assertions that may be related to mild cognitive impairment and any tissue type.
Mild Cognitive Impairment Use Case
Cell Surface Targets for Individual Cancer Patients Analyzed with Common Fund Datasets
FEATURED

Cell Surface Targets for Individual Cancer Patients Analyzed with Common Fund Datasets

Given RNA-seq samples from a patient tumor, we screen for targets which are highly expressed in the tumor but lowly expressed across all healthy human tissues in GTEx. Detailed information about the selected target are queried from several DCCs.
Cell Surface Targets for Individual Cancer Patients Analyzed with Common Fund Datasets
Mild Cognitive Impairment Use Case
FEATURED

Mild Cognitive Impairment Use Case

Find all IDG and GTEx assertions that may be related to mild cognitive impairment and any tissue type.
Mild Cognitive Impairment Use Case

All Use Cases

Explore different use cases that utilizes data from different CFDE participating programs
Guilt by Association
Playbook Workflow Builder

Guilt by Association

Given a set of genes, connect the dots (CTD) is performed against protein & pathway graphs to obtain a small subset of highly connected genes and those that are guilty by association.
Guilt by Association
NAD As A Potential Modulator Of Aging And Energy Metabolism
Playbook Workflow Builder

NAD As A Potential Modulator Of Aging And Energy Metabolism

Crossing Gene Sets From GTEx, Metabolomics, MoTrPAC,And RummaGEO Reveals NAD As A Potential Modulator Of Aging And Energy Metabolism
NAD As A Potential Modulator Of Aging And Energy Metabolism
CFDE GMT Crossing: GTEx Aging Signatures vs MoTrPAC Exercise Gene Sets (Blood)
GeneSetCart

CFDE GMT Crossing: GTEx Aging Signatures vs MoTrPAC Exercise Gene Sets (Blood)

Aging signatures are gene expression changes linked to aging. To investigate common biological aspects of aging and exercise and identify genes affected by both, the study matched aging signatures from GTEx with MoTrPAC rat endurance training gene sets.
CFDE GMT Crossing: GTEx Aging Signatures vs MoTrPAC Exercise Gene Sets (Blood)
Coenzyme A As A Potential Modulator Of Aging And Endocrine Regulation
Playbook Workflow Builder

Coenzyme A As A Potential Modulator Of Aging And Endocrine Regulation

Crossing Gene Sets From GTEx, Metabolomics And MoTrPAC Reveals Coenzyme A As A Potential Modulator Of Aging And Endocrine Regulation
Coenzyme A As A Potential Modulator Of Aging And Endocrine Regulation
Compounds to Reverse Disease Signatures
Playbook Workflow Builder

Compounds to Reverse Disease Signatures

Using differential expression signatures from two independent sources, identify and rank Consensus L1000 Small Molecules capable of reversing the expression signatures. We consider a case study involving Aging signatures between GTEx and GEO, drugs proposed should be considered as potential treatments for aging.
Compounds to Reverse Disease Signatures
Analysis of Alexander Disease Gene Sets
GeneSetCart

Analysis of Alexander Disease Gene Sets

Alexander disease (AxD) is caused by a GFAP gene mutation, leading to an accumulation of GFAP protein. This excess GFAP leads to Rosenthal fibers (RFs) in astrocytes. We use the G2SG pipeline to analyze gene sets created by comparing gene expression samples obtained from GEO of wild type (WT) or controls to Alexander disease samples.
Analysis of Alexander Disease Gene Sets
Predict Small Molecules that are Likely to Induce Specific Birth Defects
Playbook Workflow Builder

Predict Small Molecules that are Likely to Induce Specific Birth Defects

We obtain gene sets from MGI, HPO, GWAS, and PubMed associated with a given birth defect and independently find FDA Approved Drugs from LINCS Chemical Perturbations which on average down regulate the genes in the set.
Predict Small Molecules that are Likely to Induce Specific Birth Defects
This repository is under review for potential modification in compliance with Administration directives.